SOURCE: MedPage Today
DATE: March 1, 2011
EXCERPT: "Too few clinical trials of cardiac devices adequately address safety and efficacy in women, despite long-standing requirements by the FDA to do so, a review of premarket approvals showed." more
RELATED PUBMED LINK:
Dhruva SS, Bero LA, Redberg RF. Gender Bias in Studies for Food and Drug Administration Premarket Approval of Cardiovascular Devices. Circ Cardiovasc Qual Outcomes. 2011 Mar 1.
*Note: if you do not have access to this journal, contact your local librarian for assistance in accessing this article through library resources.